logo
Select company
Select metric
$ -169.76MConsolidated Income
VS
Market
8
Sector
14
Industry
18
History
9
$ 0.2Close
$ 0.04 - $ 0.84 52-Week Range
Ticker Information

Ticker

ADAP

Company Name

ADAPTIMMUNE THERAPEUTICS PLC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ADAPTIMMUNE THERAPEUTICS PLC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ADAP - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -169.76M
3/31/2025$ -69.89M
12/31/2024$ -70.81M
9/30/2024$ -44.52M
6/30/2024$ -72.5M
3/31/2024$ -163.41M
12/31/2023$ -113.87M
9/30/2023$ -95.2M
6/30/2023$ -91.02M
3/31/2023$ -114.16M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ADAPTIMMUNE THERAPEUTICS PLC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -122.84M.
  • Over the past 5 years, ADAPTIMMUNE THERAPEUTICS PLC's average Cons. Inc. has been $ -127.39M.
  • The median Cons. Inc. for ADAPTIMMUNE THERAPEUTICS PLC during this period was $ -134.89M
  • ADAPTIMMUNE THERAPEUTICS PLC reached its highest Cons. Inc. over the past 5 years at $ -44.52M.
  • The lowest Cons. Inc. recorded by ADAPTIMMUNE THERAPEUTICS PLC in the same timeframe $ -176.04M

ADAPTIMMUNE THERAPEUTICS PLC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
XFOR : X4 PHARMACEUTICALS INC $ -101.98MAYTU : AYTU BIOPHARMA INC $ -13.56MCRIS : CURIS INC $ -38.92MIRIX : IRIDEX CORP $ -5.45MBCAB : BIOATLA INC $ -59.52MCOSM : COSMOS HEALTH INC $ -15.37MGBIO : GENERATION BIO CO $ -72.42MHBIO : HARVARD BIOSCIENCE INC $ -57.41MICU : SEASTAR MEDICAL HOLDING CORP $ -14.67MCING : CINGULATE INC $ -17.96M

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

ADAP - Consolidated Income, Last 5 years

$ -176.04M

Minimum

Jun 30, 2022

$ -44.52M

Maximum

Sep 30, 2024

$ -127.39M

Average

$ -134.89M

Median

Cons. Inc. Benchmark Analysis

The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.05M with a standard deviation of $ 116.48M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.05M
median$ -2.09M
std$ 116.48M